Faruk Skenderi

Doctor of Science (PhD), Pathology, University of Zagreb School of Medicine, Croatia (2021)

Pathologist, Board-certified (2017)

Pathology Resident, University of Sarajevo Clinical Center (2012 – 2017)

Master of Science (MSc), University of Sarajevo (BiH) and University of Rijeka, Croatia (2009 – 2011)

Research fellow, Center for Proteomics, University of Rijeka, Croatia (2009 – 2010)

Medical Doctor (MD), University of Sarajevo Faculty of Medicine, BiH (2007)

Consultant Pathologist, Precision Diagnostics (2025 – present)

• Breast pathology, molecular pathology, oncology

CEO and consultant, GenoLab Ltd. (2021 – present)

• Providing precision medicine services and consultations

Head of Pathology Lab, UniMed, Sarajevo School of Science and Technology (2023 – 2026)

• Overseeing diagnostic pathology service and laboratory management

Pathologist, University of Sarajevo Clinical Center (2017 – 2021)

• Specialized in tissue and biomarker analysis of breast lesions as a member of a multidisciplinary breast cancer treatment team

Pathology resident, University of Sarajevo Clinical Center (2012 – 2017)

Assistant Professor of Pathology, Medical School, Sarajevo School of Science and Technology (2023 – 2026)

• Teaching Pathology to medical students

Lecturer, University of Sarajevo Faculty of Health Sciences (2015 – 2022)

• Undergraduate courses in Pathology and Pathophysiology, Histopathology techniques, Morphology methods for students of Health Sciences

Lecturer, University of Sarajevo Medical Faculty (2017 – 2019)

• Undergraduate courses in Pathology for medical school students

Teaching and research assistant, University of Sarajevo Medical Faculty (2007 – 2011)

• Courses in Biochemistry for medical school students

Managing Editor, Biomolecules and Biomedicine (2014 – present)

Associate Editor, BMC Cancer Cell International (2019 – 2020)

President, Association of Pathologists and Cytologists of FBiH (2019 – present)

Organizer, Bryan Warren School of Pathology (2012 – present)

Organizer, Bosnian-Turkish School of Cytopathology (2016 – present)

Diagnostic and research histopathology (breast pathology, kidney pathology)

Diagnostic and research immunohistochemistry (IHC) and in situ hybridization (ISH)

Hybridoma and monoclonal antibody technology

Cell lines, flow cytometry, PCR, Western blot, ELISA

United States and Canadian Academy of Pathology (USCAP)

European Society of Pathology (ESP)

International Society for Urological Pathology (ISUP)

Association of Pathologists and Cytologists of FBiH

Association of Basic Medical Sciences of FBiH

USCAP Global Partner award (2021, 2019)

BDIAP Nermin Duraković award (2024, 2018, 2014)

Marie Curie Actions, Early-stage research fellow (2009 – 2010)

Erasmus Mundus Basileus fellowship (2009)

Dean's award for excellence (2006)

Breast Cancer: Basic and Clinical Research

International Journal of Oncology

Frontiers in Oncology

Biomolecules and Biomedicine

BMC Cancer Cell International

Bosnian Journal of Basic Medical Sciences

Journal of Health Sciences

Monoclonal antibodies in the treatment of malignant and infectious diseases. Postgraduate course: Modern vaccines in medicine and vaccination. 24 April 2025, Mostar, BiH

From 0–100 tests/year in 36 months — a case study from Bosnia and Herzegovina. Distributors meeting, 19–20 May 2025, Prague, Czech Republic

Preparing pathologists for the digital and molecular era. Ljudevit Jurak symposium, 6–7 June 2025, Zagreb, Croatia

Navigating the process: A guide to publishing a scientific paper. Regional symposium of young endocrinologists, 2–4 June 2023, Sarajevo, BiH

Production and application of monoclonal antibodies in the treatment of malignant and infectious diseases. Postgraduate course: Modern vaccines in medicine and vaccination, 24 April 2023, Mostar, BiH

Scientific publishing: How to choose the ideal journal for your paper? Symposium: Question for science: Vaccination or smart drugs? 24 April 2023, Mostar, BiH

Novelties in pediatric pathology: transition from tissue to molecular diagnostics. 3rd Congress of the IAPP, 2–4 December 2022, Belgrade, Serbia

How to write and publish a scientific paper. 3rd Congress of the IAPP, 2–4 December 2022, Belgrade, Serbia

The role of the PIK3CA mutation in breast cancer from a pathologist's perspective. 10 December 2020, Webinar

Mammaprint and Blueprint from the pathologist's perspective. 30 November 2020, Webinar

PD-L1 testing experience in Bosnia and Herzegovina. 20 October 2020, Webinar

Defeating the remaining HER2-positive breast cancer. 6 August 2020, Webinar

Triple negative breast carcinoma (TNBC). From triple-negative to PD-L1 positive breast cancer, 16 June 2020, Webinar

Pseudojournals: why bother? Round table at the Montenegrin Academy of Sciences and Arts, 25 October 2019, Podgorica, Montenegro

PD-L1 expression and associations in tumor biology. Young Oncologist Academy on Immunotherapy, 25–27 May 2018, Tarcin, BiH

The importance of the pre-analytical phase in the pathological molecular evaluation of breast cancer. Symposium on Breast cancer and treatment modalities, 27 October 2017, Clinical Center University of Sarajevo, BiH

Neuroendocrine carcinoma of the breast: A retrospective review. 3rd Congress of Pathologists of BiH, 2–3 November 2016, Sarajevo, BiH

Warthin-like papillary renal cell carcinoma with prominent lymphocytic infiltrate. XXXI International Congress of the IAP and 28th Congress of the European Society of Pathology, 25–29 September 2016, Cologne, Germany

Isolation and characterization of monoclonal antibodies specific to the m74 gene product of mouse cytomegalovirus. 1st Symposium of the Geneticists of BiH, 17–18 February 2011, Sarajevo, BiH